Patients as Partners Europe 2022

The Conference Forum is a life science industry research firm that brings key people together to share and exchange ideas and information on how to get therapeutics to patients faster.

Now celebrating our 10th year, we continue to examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common, patient-centered goals.

Each of our key research areas – Clinical Trial Innovation, Patients as Partners, R&D Leadership, Immuno-Oncology, Drug Delivery and Clinical Research as a Care Option – has a dedicated conference, quarterly newsletter and podcasts.

We present both public and private strategic-level conferences, as well as convening focus groups and advisory boards for professionals in the life sciences and healthcare community. We also provide specialized marketing services to support thought leadership, branding and lead generation.

Experts from Novartis, Pfizer, Merck, EMD Serono, Janssen, Johnson & Johnson, GSK, Ipsen, UCB, Takeda, AbbVie, Noema Pharma, Gilead Sciences, and Pierre Fabre will gather with patient advocacy to address

Ten years ago, Greg Simon, who was the Head of Policy at Pfizer at the time and served as President of the Biden Cancer Initiative, asked our DPharm audience:

when was the last time you thanked your patients for being in a clinical trial? No one raised their hand. My immediate thought was that there was an urgent need for a conference on customer service for patients in clinical trials.

We began to research the topic within the pharmaceutical industry and received enlightening feedback: we can’t look at patients as customers, we can’t directly communicate with patients, there are privacy laws, we don’t directly work with patients, and more.

We learned that often people who have direct contact with patients are not necessarily trained to work with patients to empathize with their condition and lifestyle.